Delivery Order SPE2DB24D8002-SPE2DB25FJNYG
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,073.07 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of ENTRESTO 24 MG-26 MG TABLET 60S. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. The contract, which does not have a set-aside designation, allows Dakota Drug, Inc....
This federal contract award, valued at $6,782.38, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC), identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA...
This federal contract award, valued at $6,292.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product ENTRESTO 97 MG-103 MG TABLET 60S, with a period of performance through May 21, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,052.23, is for the delivery of ENTRESTO 49 MG-51 MG tablets to support U.S. Armed Forces medical operations. The award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to provide...
This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,443.39 firm fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. This award is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,313.18 to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of 60 tablets of the pharmaceutical product Entresto, a medication used to treat heart failure. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA under the agency's ECAT Generation V...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,816.41 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
The U.S. Defense Logistics Agency (DLA) awarded a $2,206.74 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 60 tablets of the prescription medication Entresto (24 mg-26 mg) to support U.S. Armed Forces medical operations. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQBV, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,117.23 Firm Fixed Price delivery order is for the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S. The award is not associated with a set-aside program and has an ultimate completion date of November 29, 2023. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite...
This federal contract award, with a total ceiling value of $13,171.68, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business and for-profit Subchapter S corporation. The contract, identified as SPE2DB24D8001 and SPE2DB24FKZCS, is a delivery order for the provision of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows...